Our results indicate that HPV negative head and neck cancer patients with low Gli-protein expression are  ́high-risk patients’ with worse overall- and disease-free survival, and subsequently should be closely monitored, so as to enable early detection of disease progression and initiate proper salvage treatment options. This evidence concerns the gene GLI1 and head and neck cancer.